Establishment of patient-derived tumor spheroids for non-small cell lung cancer.

The prognosis of advanced non-small cell lung cancer (NSCLC) patients is poor. One of the reasons for this hampered progress has been a lack of in vitro models that would faithfully recapitulate the heterogeneity of tumors and response to treatment. 

View Link

Leave a Reply

Your email address will not be published.